Industry Spotlight: Soligenix

CLF CEO, Susan Thornton had the chance to sit down with Dr Rick Straube, Senior VP and Chief Medical Officer of Soligenix, Inc. recently to talk about their clinical trial for treating early stage cutaneous lymphoma. The treatment process uses a new topical photosensitizing agent (synthetic hypericin) and fluorescent light.

Read more about the FLASH clinical trial.

Designed and built by Giant Rabbit.